| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 24-Jan-09 | | Total Revenue | 521,755 | 493,280 | 506,300 | 431,591 | | Cost of Revenue | 250,908 | 232,835 | 246,507 | 189,176 | | | Gross Profit | 270,847 | 260,445 | 259,793 | 242,415 | | | Operating Expenses | | Research Development | 95,345 | 94,718 | 96,295 | 68,451 | | Selling General and Administrative | 87,108 | 126,149 | 146,007 | 110,853 | | Non Recurring | 24,274 | 1,450 | 58,026 | 27,853 | | Others | 17,052 | 17,052 | 21,385 | 13,229 | | | | Total Operating Expenses | 223,779 | 239,369 | 321,713 | 220,386 | | | | Operating Income or Loss | 47,068 | 21,076 | (61,920) | 22,029 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 504 | 756 | 431 | (4,675) | | Earnings Before Interest And Taxes | 47,572 | 21,832 | (61,489) | 17,354 | | Interest Expense | 20,681 | 22,845 | 26,398 | 21,357 | | Income Before Tax | 26,891 | (1,013) | (87,887) | (4,003) | | Income Tax Expense | (6,707) | 20,021 | (24,769) | 22,028 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,598 | (21,034) | (63,118) | (26,031) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,598 | (21,034) | (63,118) | (26,031) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,598 | ($21,034) | ($63,118) | ($26,031) |
|
0.11% Nasdaq 
0.04 (0.51%) 
Income Statement
